Your account has not been permission, data will display ***. Please Upgrade to use. Close notice
Hướng dẫn sử dụng

Danapha Pharmaceutical Joint Stock Company (UPCoM: DAN)

28,500

(%)
03/28/2024 15:19

Open28,500

High28,500

Low28,500

Vol

Market Cap.596.73

Remain Bid4,500

Remain Ask300

52Wk High35,600

52Wk Low19,500

52Wk Avg Vol206

Foreign Buy-

Frgn Owned(%)0.10

Dividend700

Dividend Yield0.02

Beta-1.11

EPS3,691

P/E7.72

F P/E-

BVPS33,952

P/B0.84

Financial ratios of latest trading date, EPS in the company's latest quarter Financial Statement
View with DAN: VNM PAC PBC PME REE
Trending: VND (132,426) - HPG (113,797) - NVL (110,511) - DIG (98,703) - MBB (72,317)
1 day | 5 day | 3 months | 6 months | 12 months
DateCloseChangeVolume
03/28/202428,5000 (0.00%)0
03/27/202428,5000 (0.00%)0
03/26/202428,5000 (0.00%)0
03/25/202428,5000 (0.00%)0
03/22/202428,500-500 (-1.72%)1,000
Volume: share, Price: Dong
Unit: Million Dong
Unit: Million Dong
08/09/2023DAN Dividend payment in cash with 7.00% for 2022 (Record date)
08/09/2023DAN Dividend payment in cash with 7.00% for 2022
08/24/2022DAN Dividend payment in cash with 12.00% for 2021 (Record date)
08/24/2022DAN Dividend payment in cash with 12.00% for 2021
03/25/20242024 Annual Shareholders’Meeting Documents (Adjust)
03/08/20242024 Annual Shareholders’Meeting Documents
03/13/2024Annual report 2023
03/06/2024Explanation for FS 2023
03/06/2024Audited FS 2023

Danapha Pharmaceutical Joint Stock Company

Name: Danapha Pharmaceutical Joint Stock Company

Abbreviation:DANAPHA

Address: 253 Dũng Sĩ Thanh Khê - Q.Thanh Khê - Tp.Đà Nẵng

Telephone: (84.236) 376 0126

Fax: (84.236) 376 0127

Email:info@danapha.com

Website:http://www.danapha.com

Exchange: UPCoM

Sector: Manufacturing

Industry: Chemical - Pharmaceutical

Listing date: 12/22/2021

Chartered capital: 209,380,000,000

Listed shares: 20,938,000

Shares outstanding: 20,938,000

Status: Operating

Tax code: 0400102091

Establishment license: 0400102091

Issued date: 12/20/2006

Business license: 400102091

Issued date: 06/20/2006

Main business scope:

- Sản xuất, kinh doanh và XNK các mặt hàng thuốc chữa bệnh, mỹ phẩm, nguyên liệu sản xuất thuốc và bao bì dược phẩm
- Tổ chức các chương trình nghiên cứu khoa học và cung ứng nguồn nguyên liệu chủ yếu cho nền sản xuất dược phẩm Việt Nam...

ItemsUnit
PriceVND
VolumeShares
Foreigner's, Yield%
Mkt CapbVND
Financial indicatorsmVND
EPS, BVPS, DividendVND
P/E, F P/E, P/BTimes
ROS, ROA, ROE%
1. The accounting period for the equitization year is defined as of the company's establishment date.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
* Vietstock tổng hợp thông tin từ các nguồn đáng tin cậy vào thời điểm công bố cho mục đích cung cấp thông tin tham khảo. Vietstock không chịu trách nhiệm đối với bất kỳ kết quả nào từ việc sử dụng các thông tin này.